Pediatric inflammatory bowel disease

Child and Adolescent Psychiatric Clinics of North America

Volumn 12, Issue 3, 2003, Pages 537-550

  King, Robert A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; ENEMA; FOLIC ACID ANTAGONIST; IMMUNOMODULATING AGENT; INFLIXIMAB; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PURINE DERIVATIVE; SALAZOSULFAPYRIDINE; SUPPOSITORY BASE;

ACNE; ADOLESCENT; AWARENESS; BEHAVIOR DISORDER; BONE NECROSIS; CHILD; CHILD DEVELOPMENT; CHILD HEALTH CARE; CHILD PARENT RELATION; CHILDHOOD DISEASE; CLINICAL FEATURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; CUSHINGOID SYNDROME; EDUCATION; ENTERITIS; EPIDEMIOLOGICAL DATA; GROWTH DISORDER; HIRSUTISM; HUMAN; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REMISSION; REVIEW; SIDE EFFECT; SLEEP DISORDER; STRESS; STRIA; TREATMENT OUTCOME; ULCERATIVE COLITIS; WELLBEING;

EID: 0038637471     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-4993(03)00007-5     Document Type: Review

References (53)

1. Dubinsky MC, Seidman EG. Chronic inflammatory bowel diseases. In: Rudolph CD, Rudolph AM, editors. Rudolph's pediatrics. 21st edition. New York: McGraw-Hill; 2002. p. 1435-44.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
3. Kim S, Ferry G. Inflammatory bowel diseases in children. Curr Probl Pediatr 2002;32:103-32.
4. Drossman DA. Gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998;60:258-67.
5. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999;45(Suppl 2):II25-30.
6. Leichtner AM, Jackson WD, Grand RI. Crohn's disease. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease. 2nd edition. St. Louis: Mosby; 1996. p. 692-711.
7. Buller HA. Problems in diagnosis of IBD in children. Neth J Med 1997;50:S8-11.
8. Leichtner AM, Jackson WD, Grand RI. Ulcerative colitis. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease. 2nd edition. St. Louis: Mosby; 1996. p. 712-26.
9. Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
10. Weiss ST. Eat dirt: the hygiene hypothesis and allergic diseases. N Engl J Med 2002;347:930-1.
11. Rabbett H, Elbadri R, Northover H, et al. Quality of life in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996;23:528-33.
12. Casati J, Toner BB, de Rooy EC, Drossman DA, Maunder RG. Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig Dis Sci 2000;45:26-31.
13. Decker JW. The effects of inflammatory bowel disease on adolescents. Gastroenterol Nurs 2000;23:63-6.
14. Rayhorn N. Treatment of inflammatory bowel disease in the adolescent. Journal of Infusion Nursing 2001;24:255-62.
15. Richardson G, Griffiths AM, Miller V, Thomas AG. Quality of life in inflammatory bowel disease: a cross-cultural comparison of English and Canadian children. J Pediatr Gastroenterol Nutr 2001;32:573-8.
16. Engstrom I. Inflammatory bowel disease in children and adolescents: mental health and family functioning. J Pediatr Gastroenterol Nutr 1999;28(Suppl):S28-33.
17. King RA, Lewis M. The difficult child. Child Adolesc Psychiatry Clin North Am 1994;3:531-41.
18. Akobeng AK, Miller V, Firth D, Suresh-Babu MV, Mir P, Thomas AG. Quality of life of parents and siblings of children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999;28:S40-2.
19. Tojek TM, Lumley MA, Corlis M, Ondersma S, Tolia V. Maternal correlates of health status in adolescents with inflammatory bowel disease. J Psychosom Res 2002;52:173-9.
20. Engstrom I. Parental distress and social interaction in families with children with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991;30:904-12.
21. Wood B, Boyle JT, Watkins JB, Nogueira J, et al. Sibling psychological status and style as related to the disease of their chronically ill brothers and sisters: implications for models of biopsychosocial interaction. J Dev Behav Pediatr 1988;9:66-72.
22. Gerson MJ. Psychosomatics and psychoanalytic theory: the psychology of ulcerative colitis and Crohn's disease. Psychoanalytic Psychology 2002;19:380-8.
23. Fyvie P. Ostomy care. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease. 2nd edition. St. Louis: Mosby; 1996. p. 2107- 13.
24. O'Brien BK. Coming of age with an ostomy. Am J Nurs 1999;99:71-6.
25. Ferry GD. Quality of life in inflammatory bowel disease: background and definitions. J Pediatr Gastroenterol Nutr 1999;28:S15-8.
26. Koot HM, Bouman HN. Potential uses for quality of life measures in childhood inflammatory bowel disease. J Pediatric Gastroenterol Nutr 1999;28:S56-61.
27. Loonen HJ, Grootenhuis MA, Last BF, de Haan RJ, Bouquet J, Derkx BH. Measuring quality of life in children with inflammatory bowel disease: the impact-II (NL). Qual Life Res 2002;11:47-56.
28. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function. Am J Gastroenterol 1995;90:1450-4.
29. Gortmaker SL, Walker DK, Weitzman M, Sobol AM. Chronic conditions, socioeconomic risks, and behavioral problems in children and adolescents. Pediatrics 1990;85:267-76.
30. Wood B, Watkins JB, Boyle JT, Nogueira J, Zimand E, Carroll L. Psychological functioning in children with Crohn's disease and ulcerative colitis: implications for models of psychological interaction. J Am Acad Child Adolesc Psychiatry 1987;26:774-81.
31. Engstrom I. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J Child Psychol Psychiatry 1992;33:563-82.
32. Lavigne J, Faier-Routman J. Psychological adjustment to pediatric physical disorders: a metaanalytic review. J Pediatr Psychol 1992;17:133-57.
33. Steinhausen HC, Kies H. Comparative studies of ulcerative colitis and Crohn's disease in children and adolescents. J Child Psychol Psychiatry 1982;23:33-42.
34. Burke P, Meyer V, Kokoshis S, Orenstein D, et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989;28:948-51.
35. Burke PM, Neigut D, Kocoshis S, Chandra R, Sauer J. Correlates of depression in new onset pediatric inflammatory bowel disease. Child Psychiatry Hum Dev 1994;24:275-83.
36. Burke P, Kocoshis SA, Chandra R, Whiteway M, Sauer J. Determinants of depression in recent onset pediatric inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1990;29:608-10.
37. Engstrom I. Family interaction and locus of control in children and adolescents with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991;30:913-20.
38. Duffy LC, Zielezny MA, Marshall JR, et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med 1991;17:101-10.
39. Mayer EA. Psychological stress and colitis. Gut 2000;46:595-6.
40. Qui BS, Vallance BA, Blennerhassett PA, Collins SM. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 1999;5:1178-82.
41. Wood JD, Peck OC, Tefend KS, et al. Colitis and colon cancer in cotton-top tamarins (Saguinus oedipus oedipus) living wild in their natural habitat. Dig Dis Sci 1998;43:1443-53.
42. Anton PA, Shanahan F. Neuroimmunomodulation in inflammatory bowel disease: How far from "bench" to "bedside"? Ann N Y Acad Sci 1998;840:723-34.
43. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 2001;169:429-35.
44. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002;20:125-63.
45. Eskandari F, Sternberg EM. Neural-immune interactions in health and disease. Ann N Y Acad Sci 2002;966:20-7.
46. Janeway CA, Travers P, Walport M, Shlomchik M. Immunobiology: the immune system in health and disease. 5th edition. New York: Garland Publishing; 2001.
47. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:1106-15.
48. Shanahan F. Brain-gut axis and mucosal immunity: a perspective on mucosal psychoneuroimmunology. Semin Gastrointest Dis 1999;10:8-13.
49. Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men: a 2-year follow-up study. Arch Gen Psychiatry 1997;54:279-85.
50. Leserman J, Petitto JM, Golden RN, Gaynes BN, Gu H, Perkins DO, et al. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatry 2000;157:1221-8.
51. Drossman DA, Leserman J, Li Z, Keefe F, Hu YJB, Toomey TC. Effects of coping on health outcome among women. Psychosomatic Medicine 2000;62:309-17.
52. Casati J, Toner BB. Psychosocial aspects of inflammatory bowel disease. Biomed Pharmacother 2000;54:388-93.
53. Ellett ML, Schibler K. Adolescent psychosocial adaptation to inflammatory bowel disease. Journal of Pediatric Health Care 1988;2:57-66.